Company intelligence / Profile preview

Quinnova Pharmaceuticals

Jamison, Pennsylvania, United Statesquinnova.com ↗
Ownership
Private
Employees
~73
Development stage
Other
01

Overview

Quinnova has FDA-approved products on the market including NEOSALUS brand foam and cream, and Ecoza (econazole nitrate) topical foam for fungal infections

Therapeutic areas
DermatologyInfectious Diseases
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

2 assets

KPV peptide

Preclinical

1 more asset in the full pipeline.

03

Partnerships

Amneal Enterprises (2010-2015 period)Exeltis (current parent through Everett Laboratories acquisition)

Beyond the preview

Go deeper on Quinnova Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quinnova Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call